The Effect of Lumify™ Eyedrops on Eyelid Position

Completed · Phase 4 · Has a placebo group

Conditions studied: Eyelid Droop

In brief

The purpose of the research is to see if Lumify™ has an effect on eyelid position.

Key facts

Study ID: NCT03782701
Run by: University of Miami
People needed: 43
Starts: 2019-06-18
Expected to finish: 2020-04-01
Last updated by the study team: 2021-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Adults age 18 and above able to provide informed consent to participate
Subject with stable ocular health, defined as no ocular conditions requiring ongoing topical therapy or recent surgical intervention

You may not qualify if…

Adults unable to consent
Prisoners
Pregnant women.
Known contradictions or sensitivities to study medication (brimonidine)
Ocular surgery within the past 3 months or refractive surgery within the past six months
Grossly abnormal lid margins, anatomical abnormalities, previous eyelid or orbital surgery
Variable ptosis or eyelid position (e.g., myasthenia gravis, thyroid eye disease, or blepharospasm)
Significant pre-existing ptosis of any cause (defined as margin reflex distance 1 < 1mm)
Any ocular or systemic condition that, in the opinion of the investigator, would confound study data, interfere with the subject's study participation, or affected the subject's safety or trial parameters
Presence of an active ocular infection
Prior (within 5 days of beginning study treatment) use of eye whiteners (eg, vasoconstrictors), decongestants, antihistamines (including over the counter and herbal topical ophthalmic medications), phenylephrine dilating drops, any other topical ophthalmic agents
Inability to sit comfortably for 15 - 30 minutes

Where it is running

Bascom Palmer Eye Institute — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.